In a study of renal cancer, CAFs were found to up-regulate tryptophan 2, 3-dioxygenase (TDO) expression, resulting in enhanced secretion of Kyn, which ultimately activate AKT and STAT3 signaling pathways and induce chemoresistance [237]. The gene discussed is TDO2; the disease is renal carcinoma.